| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 15 |
| 1 | PEMBROLIZUMAB | 14 |
| 2 | PACLITAXEL | 12 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 12 |
| 4 | NIVOLUMAB | 9 |
| 5 | ATEZOLIZUMAB | 6 |
| 6 | IPILIMUMAB | 6 |
| 7 | MYCOPHENOLATE MOFETIL | 6 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 6 |
| 9 | PREDNISONE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXCHLORPHENIRAMINE MALEATE | 1 | 0.0010 |
| 1 | WHITE PETROLATUM | 1 | 0.0007 |
| 2 | HYDROCORTISONE BUTYRATE | 1 | 0.0005 |
| 3 | SKIN PROTECTANT | 1 | 0.0004 |
| 4 | BRENSOCATIB | 1 | 0.0004 |
| 5 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 6 | AVELUMAB | 1 | 0.0002 |
| 7 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| 8 | ATEZOLIZUMAB | 6 | 0.0002 |
| 9 | INDOMETHACIN | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 29 | 0.0003 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 6 | 0.0001 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 4 | Microtubule Inhibitor [EPC] | 12 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 15 | 0.0001 |
| 6 | Bile Acid [EPC] | 1 | 0.0000 |
| 7 | Integrin Receptor Antagonist [EPC] | 3 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |